A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer

Date
2011
Author
Camci, C.
Sencan, O.
Yilmaz, U.
Zengin, N.
Buyukunal, E.
Buyukberber, S.
Kilickap, S.
Yalcin, S.
Uslu, R.
Dane, F.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/95894
https://doi.org/10.1200/jco.2011.29.4_suppl.474
Collections